PRKZX
Price
$7.53
Change
-$0.08 (-1.05%)
Updated
Nov 12 closing price
Net Assets
56.63M
VRTPX
Price
$21.78
Change
-$0.17 (-0.77%)
Updated
Nov 12 closing price
Net Assets
9.6B
Interact to see
Advertisement

PRKZX vs VRTPX

Header iconPRKZX vs VRTPX Comparison
Open Charts PRKZX vs VRTPXBanner chart's image
PGIM Real Estate Income Z
Price$7.53
Change-$0.08 (-1.05%)
VolumeN/A
Net Assets56.63M
Vanguard Real Estate II Index
Price$21.78
Change-$0.17 (-0.77%)
VolumeN/A
Net Assets9.6B
PRKZX vs VRTPX Comparison Chart in %
View a ticker or compare two or three
VS
PRKZX vs. VRTPX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRKZX is a Buy and VRTPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VRTPX has more cash in the bank: 9.6B vs. PRKZX (56.6M). VRTPX pays higher dividends than PRKZX: VRTPX (3.81) vs PRKZX (3.54). PRKZX was incepted earlier than VRTPX: PRKZX (10 years) vs VRTPX (8 years). PRKZX (2.83) is less costly to investors than VRTPX (0.08). PRKZX is a more actively managed with annual turnover of: 112.00 vs. VRTPX (4.00). PRKZX has a lower initial minimum investment than VRTPX: PRKZX (0) vs VRTPX (100000000). VRTPX annual gain was more profitable for investors over the last year : 0.01 vs. PRKZX (-2.42). VRTPX return over 5 years is better than : 27.92 vs. PRKZX (6.89).
PRKZXVRTPXPRKZX / VRTPX
Total Expense Ratio1.100.081,375%
Annual Report Gross Expense Ratio2.830.083,538%
Fund Existence10 years8 years-
Gain YTD4.0644.57989%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets56.6M9.6B1%
Annual Yield % from dividends3.543.8193%
Returns for 1 year-2.420.01-17,444%
Returns for 3 years29.1017.40167%
Returns for 5 years6.8927.9225%
Returns for 10 years35.36N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNMSF304.0013.49
+4.65%
Genmab A/S
KMRCF9.42N/A
N/A
Komori Corp.
PEBC65.00N/A
N/A
Peoples Bancorp Inc.
ASOZF64.73N/A
N/A
Asseco Poland S.A.
SKVI0.46-0.02
-3.36%
Skinvisible, Inc.